• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

动脉僵硬度可能预测常染色体显性多囊肾病的肾脏和心血管预后。

Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.

作者信息

Sági B, Késői I, Késői B, Vas T, Csiky B, Kovács T, Nagy J

机构信息

1 2nd Department of Internal Medicine and Nephrological Centre, Clinical Centre, Medical School, University of Pécs , Pécs, Hungary.

2 Internal Medicine Department, Mining Rehabilitation and Night Time Sanatorium, Health Centre of Komló , Komló, Hungary.

出版信息

Physiol Int. 2018 Jun 1;105(2):145-156. doi: 10.1556/2060.105.2018.2.17.

DOI:10.1556/2060.105.2018.2.17
PMID:29975128
Abstract

Background and aims Autosomal-dominant polycystic kidney disease (ADPKD) is one of the most common causes of end-stage renal disease (ESRD). The most important cause of death among ADPKD patients is cardiovascular (CV). The aim of this study was to examine the prognostic significance of arterial stiffness on CV and renal outcomes in ADPKD. Methods A total of 55 patients with ADPKD were examined. Pulse wave velocity was determined and stiffness index (SI) was calculated. Combined primary endpoints (CV and renal) were major CV events (myocardial infarction, stroke, and CV intervention) as CV endpoints, and attaining of ESRD or start of renal replacement therapy as renal endpoints. Secondary endpoints were CV or renal endpoints separately. Results The mean age of those 55 ADPKD patients was 45 ± 12 years, 21 patients were male. The average value of the SI was 11.11 ± 2.22 m/s. The patients were divided into two groups by the cutoff value of 11 m/s of SI and then outcomes were analyzed. In the higher arterial stiffness group (SI > 11 m/s), occurrence of combined primary endpoint (CV and renal) was significantly higher than in the group with more elastic arteries (p = 0.033). A statistically significant difference was found in the renal endpoints (p = 0.018), but not in the CV endpoints (p = 0.952) between the two groups. Conclusions Increased arterial stiffness predicts the onset of ESRD in ADPDK. Assessment of SI appears to be a useful method for estimating the renal and CV prognosis in ADPKD.

摘要

背景与目的 常染色体显性遗传性多囊肾病(ADPKD)是终末期肾病(ESRD)最常见的病因之一。ADPKD患者最重要的死亡原因是心血管(CV)疾病。本研究旨在探讨动脉僵硬度对ADPKD患者心血管和肾脏结局的预后意义。方法 共检查了55例ADPKD患者。测定脉搏波速度并计算僵硬度指数(SI)。联合主要终点(心血管和肾脏)作为心血管终点是主要心血管事件(心肌梗死、中风和心血管干预),作为肾脏终点是达到ESRD或开始肾脏替代治疗。次要终点分别是心血管或肾脏终点。结果 55例ADPKD患者的平均年龄为45±12岁,男性21例。SI的平均值为11.11±2.22m/s。根据SI的临界值11m/s将患者分为两组,然后分析结局。在动脉僵硬度较高的组(SI>11m/s)中,联合主要终点(心血管和肾脏)的发生率显著高于动脉弹性较好的组(p=0.033)。两组之间在肾脏终点方面存在统计学显著差异(p=0.018),但在心血管终点方面无差异(p=0.952)。结论 动脉僵硬度增加可预测ADPKD患者ESRD的发生。评估SI似乎是评估ADPKD患者肾脏和心血管预后的一种有用方法。

相似文献

1
Arterial stiffness may predict renal and cardiovascular prognosis in autosomal-dominant polycystic kidney disease.动脉僵硬度可能预测常染色体显性多囊肾病的肾脏和心血管预后。
Physiol Int. 2018 Jun 1;105(2):145-156. doi: 10.1556/2060.105.2018.2.17.
2
Vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease.常染色体显性多囊肾病儿童及青年的血管功能障碍
Nephrol Dial Transplant. 2017 Feb 1;32(2):342-347. doi: 10.1093/ndt/gfw013.
3
The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease.PROPKD评分:一种预测常染色体显性多囊肾病肾脏存活情况的新算法。
J Am Soc Nephrol. 2016 Mar;27(3):942-51. doi: 10.1681/ASN.2015010016. Epub 2015 Jul 6.
4
Imaging Identification of Rapidly Progressing Autosomal Dominant Polycystic Kidney Disease: Simple Eligibility Criterion for Tolvaptan.常染色体显性遗传多囊肾病的影像学识别:托伐普坦的简单入选标准。
Am J Nephrol. 2020;51(11):881-890. doi: 10.1159/000511797. Epub 2020 Nov 23.
5
The Association of Fibroblast Growth Factor 23 with Arterial Stiffness and Atherosclerosis in Patients with Autosomal Dominant Polycystic Kidney Disease.成纤维细胞生长因子23与常染色体显性多囊肾病患者动脉僵硬度和动脉粥样硬化的关联
Kidney Blood Press Res. 2018;43(4):1160-1173. doi: 10.1159/000492244. Epub 2018 Jul 31.
6
Prevalence and predicting factors of increased arterial stiffness in autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病患者中动脉僵硬度增加的流行情况及其预测因素。
Saudi J Kidney Dis Transpl. 2021 Mar-Apr;32(2):481-487. doi: 10.4103/1319-2442.335460.
7
Renal volume and cardiovascular risk assessment in normotensive autosomal dominant polycystic kidney disease patients.正常血压的常染色体显性多囊肾病患者的肾体积与心血管风险评估
Medicine (Baltimore). 2016 Dec;95(49):e5595. doi: 10.1097/MD.0000000000005595.
8
Cardiovascular risk factors and the impact on prognosis in patients with chronic kidney disease secondary to autosomal dominant polycystic kidney disease.常染色体显性遗传多囊肾病继发慢性肾脏病患者的心血管危险因素及其对预后的影响。
BMC Nephrol. 2021 Mar 25;22(1):110. doi: 10.1186/s12882-021-02313-1.
9
Mean platelet volume and its relation with arterial stiffness in patients with normotensive polycystic kidney disease.平均血小板体积与血压正常型多囊肾病患者动脉僵硬度的关系。
J Investig Med. 2013 Mar;61(3):597-603. doi: 10.2310/JIM.0b013e31828218e7.
10
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.2001 - 2010年美国常染色体显性多囊肾病导致的终末期肾病
Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16.

引用本文的文献

1
The Relationship between Vascular Biomarkers (Serum Endocan and Endothelin-1), NT-proBNP, and Renal Function in Chronic Kidney Disease, IgA Nephropathy: A Cross-Sectional Study.血管生物标志物(血清内皮素和内脂素 1)、NT-proBNP 与慢性肾脏病 IgA 肾病患者肾功能的关系:一项横断面研究。
Int J Mol Sci. 2024 Sep 30;25(19):10552. doi: 10.3390/ijms251910552.
2
Does Metabolic Syndrome and Its Components Have Prognostic Significance for Renal and Cardiovascular Outcomes in IgA Nephropathy?代谢综合征及其组分对IgA肾病的肾脏和心血管结局是否具有预后意义?
Biomedicines. 2024 Jun 4;12(6):1250. doi: 10.3390/biomedicines12061250.
3
The Role of Two Heart Biomarkers in IgA Nephropathy.
两种心脏生物标志物在 IgA 肾病中的作用。
Int J Mol Sci. 2023 Jun 19;24(12):10336. doi: 10.3390/ijms241210336.